Research Article
Fibrinogen Level Predicts Outcomes in Critically Ill Patients with Acute Exacerbation of Chronic Heart Failure
Table 1
Summary of patient characteristics.
| | Total () | Fibrinogen () | Fibrinogen () |
| | Age (years) | | | | | BMI (kg/m2) | | | | | Gender (male), (%) | 319 (57.6) | 124 (55.1) | 195 (59.3) | | Ethnicity, (%) | | | | | White | 426 (76.9) | 174 (77.3) | 252 (76.6) | | Black | 33 (6.0) | 12 (5.3) | 21 (6.4) | | Other | 95 (17.1) | 39 (17.3) | 56 (17.0) | | Mean BP (mmHg) | | | | | Laboratory outcomes | | | | | WBC count (109/l) | | | | | Hb (mg/dl) | | | | | Scr (mg/dl) | | | | | NT-ProBNP, (%) | 70 (12.6) | 12 (5.3) | 58 (17.6) | | Platelet count (109/l) | | | | | Glucose (mg/dl) | | | | | Fibrinogen (mg/dl) | | | | | Comorbidities, (%) | | | | | Respiratory failure, (%) | 185 (33.4) | 46 (20.4) | 139 (42.2) | | HBP, (%) | 265 (47.8) | 121 (53.8) | 144 (43.8) | | DM, (%) | 224 (40.4) | 84 (37.3) | 140 (42.6) | | Af, (%) | 291 (52.5) | 123 (54.7) | 168 (51.1) | | AKI, (%) | 512 (92.4) | 210 (93.3) | 302 (91.8) | | CKD, (%) | 273 (49.3) | 89 (39.6) | 184 (55.9) | | NSTEMI, (%) | 131 (13.6) | 47 (20.9) | 84 (25.5) | | STEMI, (%) | 32 (5.8) | 7 (3.1) | 25 (7.6) | | Vasopressor use, (%) | 403 (72.7) | 177 (78.7) | 226 (68.7) | | Ventilator use, (%) | 427 (77.1) | 192 (85.3) | 235 (71.4) | | CRRT | 41 (7.4) | 11 (4.9) | 30 (9.1) | | Disease scores | | | | | SOFA scores | 6 (4-9) | 4 (7-9) | 6 (4-8) | | APS III scores | 48 (35-63) | 42 (31-58) | 52 (40-67) | | SAPS II scores | 42 (35-52) | 40 (34-51) | 44 (35-53) | | SIRS scores | 3 (2-4) | 3 (2-3) | 3 (3-4) | | Outcome | | | | | ICU LOS (days) | 4.9 (2.7-8.6) | 3.3 (2.5-6.1) | 6.1 (3.2-10.2) | | 28-day mortality, (%) | 82 (14.8) | 15 (6.7) | 67 (20.4) | | 90-day mortality, (%) | 133 (24.0) | 25 (11.1) | 108 (32.8) |
|
|
